Donald Trump announced tariffs on several areas including pharmaceuticals late Thursday night. The impact of the impact of 100% tariff on pharmaceuticals is on the Indian stock market today. The Indian stock market is trading under pressure today. Pharma shares with significant investment in the US have declined. The Sensex fell 412.67 points to 80,747.01 and the Nifty fell 115 points to close at 24,776.
Following the tariff announcement of Trump, five Indian pharma stocks including Arvindo, Lupine, DRL, Sun and Biocon have declined drastically. Arvindo Pharma is trading at 1.91% to ₹ 1,076. Lupine shares are trading at ₹ 1918.60.
Sun Pharma shares are trading at 1580 with a decline of about 3 percent. Cipla’s shares have fallen by 2 percent. Strides Pharma Science has fallen by 6 percent, 5 percent in Natco Pharma, 4 percent in Biocon and Mankind Pharma by 3.30 percent. The top 30 shares of BSE have fallen by 2.67 percent in the Shares of Sun Pharma. After this, 25 shares, including Infosys, Tech Mahindra and Asian Paints, have declined by 2 percent. The remaining 5 shares are rose.
